There has been a significant increase in the use of 90Y-microspheres in treating liver
malignancies. This increase could be seen over the last 30 y, and Food and Drug …

802 Objectives: Yttrium 90 for treatment of liver tumors has been available since 1999, with
continued growth observed in use of these agents.. Two Y90 agents are FDA approved for …

Materials and methods Between June 2004 and August 2006, 21 patients (11 women and
10 men; age range 40–75 years; mean, 58 years) with a wide range of extensive liver …

Therapy with 90Y-microspheres is emerging as a mainstream treatment modality in the
management of patients with primary and metastatic liver cancer (1, 2). The technique …

The nonuniformity of dose deposition for hepatic 90Y-microsphere therapy is believed to
play an important role in the relative sparing of normal liver tissues. To help study this issue …

90Yttrium microspheres for nonresectable liver cancer: the University of Connecticut Health
Center experience. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …

Normal liver complications have not been observed in Y-90 microsphere therapy of hepatic
tumors [selective internal radiation (SIR)], despite clinical studies reporting estimated …

Arterial administration of 90 Y microspheres is used for salvage therapy in patients with
primary or metastasized tumors within the liver. The clinical use of high-yield beta emitters …

INTRODUCTION: Radioactive microsphere 90Y therapy is increasingly used for primary and
metastatic solid tumors in the liver. We present an analysis of 4 explanted livers previously …

Internal radiation therapy using intrahepatic arterial injection of 90Y-labeled glass
microspheres (90Y-microspheres) has proven to be a promising therapeutic modality for …